Call Options

10 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$114.58 - $153.15 $607,274 - $811,695
-5,300 Reduced 31.55%
11,500 $1.32 Million
Q2 2024

Aug 14, 2024

BUY
$130.86 - $143.19 $2.2 Million - $2.41 Million
16,800 New
16,800 $2.31 Million
Q3 2022

Nov 15, 2022

SELL
$92.03 - $107.81 $4.11 Million - $4.82 Million
-44,700 Reduced 49.89%
44,900 $4.77 Million
Q2 2022

Aug 15, 2022

BUY
$75.79 - $100.07 $1.96 Million - $2.58 Million
25,800 Added 40.44%
89,600 $8.89 Million
Q1 2022

May 18, 2022

SELL
$72.45 - $94.81 $1.17 Million - $1.54 Million
-16,200 Reduced 20.25%
63,800 $6.1 Million
Q2 2020

Aug 14, 2020

BUY
$85.09 - $130.36 $6.81 Million - $10.4 Million
80,000 New
80,000 $9.77 Million
Q1 2020

May 14, 2020

SELL
$75.11 - $113.76 $2.25 Million - $3.41 Million
-30,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$86.8 - $118.57 $868,000 - $1.19 Million
10,000 Added 50.0%
30,000 $3.22 Million
Q2 2019

Aug 14, 2019

SELL
$72.24 - $91.27 $722,400 - $912,700
-10,000 Reduced 33.33%
20,000 $1.7 Million
Q1 2019

May 14, 2019

BUY
$69.31 - $91.53 $2.08 Million - $2.75 Million
30,000 New
30,000 $0

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.